These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 32792490)

  • 21. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic Role of MicroRNA Dysregulation in Podocytopathies.
    Liu F; Chen J; Luo C; Meng X
    Front Physiol; 2022; 13():948094. PubMed ID: 35845986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
    Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
    Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
    Audard V; Lang P; Sahali D
    Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological involvement in monogenic podocytopathies.
    Boyer O; Mollet G; Dorval G
    Pediatr Nephrol; 2021 Nov; 36(11):3571-3583. PubMed ID: 33791874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurological disorders and hereditary podocytopathies: Some fascinating pathophysiological overlaps].
    Boyer O; Mollet G; Dorval G
    Med Sci (Paris); 2023 Mar; 39(3):246-252. PubMed ID: 36943121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Educational paper: the podocytopathies.
    Büscher AK; Weber S
    Eur J Pediatr; 2012 Aug; 171(8):1151-60. PubMed ID: 22237399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
    Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
    Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent insights into the pathogenesis of nephrotic syndrome.
    Certikova-Chabova V; Tesar V
    Minerva Med; 2013 Jun; 104(3):333-47. PubMed ID: 23748287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complicated role of mitochondria in the podocyte.
    Gujarati NA; Vasquez JM; Bogenhagen DF; Mallipattu SK
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F955-F965. PubMed ID: 33073585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.
    Zhao X; Hwang DY; Kao HY
    Nucl Receptor Res; 2018; 5():. PubMed ID: 30417008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models of nephrotic syndrome.
    Simic I; Tabatabaeifar M; Schaefer F
    Pediatr Nephrol; 2013 Nov; 28(11):2079-88. PubMed ID: 23250714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructural study of podocyte alterations in non proliferative glomerulopathy].
    Sipovsky VG; Nevorotin AI; Avsiewitsch IV; Smirnov AV
    Arkh Patol; 2019; 81(3):51-58. PubMed ID: 31317931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
    Shankland SJ
    Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease.
    Popovic ZV; Bestvater F; Krunic D; Krämer BK; Bergner R; Löffler C; Hocher B; Marx A; Porubsky S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
    Liu J; Wang W
    Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.